Health Trials

Evaluation of the Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study

ConditionsMigraineMigraine DiseaseMigraine DisorderMigraine HeadacheMigraine DisabilityMigraine in AdultsMenstrual MigraineMenstrual Migraine (MM) Headaches
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorMiracle Wellness LLC

About this trial

The purpose of this study is to evaluate the impact of the Migraceutics® phase-specific dietary supplement regimen on quality of life, work productivity, and biomarkers in adult migraineurs.

Eligibility criteria

Qualifiers

Self-reported history of migraine, based on the International Headache Society (IHS) International Classification of Headache Disorders, 3rd edition (ICHD-3) diagnostic criteria for migraine.

Being able to take oral supplements.

Agreeing to maintain their regular lifestyle.

Access to internet and telephone.

Disqualifiers

Pregnancy or lactation.

Presence of any active medical condition or diagnosis other than episodic migraine, including liver or kidney disease or condition.

Use of overlapping supplements or interacting medications.

Known allergies to study ingredients.

Trial design

Treatments tested in this trial

  • Foundational dietary supplement
  • Luteal phase dietary supplement add-on
  • Migraine phase dietary supplement add-on
  • Reference dietary supplement

Treatment groups

920 Participants
are divided into 5 treatment groups

Sponsors and collaborators

Miracle Wellness LLC

Lead sponsor

Source ClinicalTrials.gov